Omalizumab modulates bronchial reticular basement membrane thickness and eosinophil infiltration in severe persistent allergic asthma patients.
about
Biomarkers and severe asthma: a critical appraisalSevere asthma: anti-IgE or anti-IL-5?Mepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potentialThe role of IgE-receptors in IgE-dependent airway smooth muscle cell remodellingTreating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a reviewNovel diagnostic approaches and biological therapeutics for intrinsic asthma.Omalizumab, an anti-immunoglobulin E antibody: state of the art.Serum IgE Induced Airway Smooth Muscle Cell Remodeling Is Independent of Allergens and Is Prevented by OmalizumabIgE induces proliferation in human airway smooth muscle cells: role of MAPK and STAT3 pathways.Mesenchymal stromal cells mediate Aspergillus hyphal extract-induced allergic airway inflammation by inhibition of the Th17 signaling pathway.Galectin-3: an early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months.New strategies with anti-IgE in allergic diseasesThe relationship between allergen immunotherapy and omalizumab for treating asthma.The discovery and development of omalizumab for the treatment of asthma.Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma.Molecular phenotyping and biomarker development: are we on our way towards targeted therapy for severe asthma?From IgE to Omalizumab.The path to personalized medicine in asthma.Pharmacokinetics, pharmacodynamics and clinical efficacy of omalizumab for the treatment of asthma.Targeting Interleukin-5 or Interleukin-5Rα: Safety Considerations.Bidirectional Mast Cell-Eosinophil Interactions in Inflammatory Disorders and Cancer.An Update on Anti-IgE Therapy in Pediatric Respiratory Diseases.Moving toward consensus on diagnosis and management of severe asthma in children.New approaches for identifying and testing potential new anti-asthma agents.Anti-IgE and Biologic Approaches for the Treatment of Asthma.Novel therapies for severe asthma in children and adults.Eosinophils from Physiology to Disease: A Comprehensive Review.
P2860
Q26782718-E7245F82-5C8A-47AA-B803-525A8AB87210Q28071832-9C8B2DEF-AB2D-4A0A-8BC2-7DEC67779100Q28080207-7356F35D-95D7-4987-945E-33012E5863F1Q28486175-9151D204-6043-4F62-91B5-9D53AE52EE81Q30801642-989E890D-E50E-4528-8C2F-DB40DE2B9583Q33904534-938689E0-A74B-419D-A683-E6877846686BQ35095218-E3C8BAF9-8E1A-434A-A364-23A537C9EA1CQ35762396-F6D3B1AE-AE08-4FEE-8A38-16BDCE41441DQ37348112-0A52F233-028D-4294-AB80-A628E2AE2E21Q37585439-479C7ACC-53CE-4F13-88CE-CC02C8E6B0F0Q37692640-2C9C6CAC-D396-49C7-B444-D579F0588F81Q38237389-806DB02D-78BC-4E60-A9E9-29D0FFC5E542Q38314276-3E70C7B2-51E2-4DD6-8633-A7F6A8DCF4BDQ38483005-9A8C96D6-EA58-4F85-A563-D6FABF512C31Q38599656-6CE2CE1E-F434-461F-B713-516A63672143Q38632790-039FFC92-890E-47CB-8FB9-23CF4885D803Q38793428-CE553EBE-16DA-4ED2-B3B0-68F7DE83AE2DQ38843261-94879378-7772-465E-B339-360790C46BFFQ38982481-550353D5-0B46-4763-A2A5-67AF41E567F2Q39189229-97FD6FF7-D23C-4ED9-BC18-81AB221F36BCQ41098587-11FAE775-F6F5-4C5C-BEA2-34D61A80BEAAQ47146658-2B0E89BA-D8F5-4C1F-BD70-24420F29EBB7Q47863226-30CC1FAD-0AA0-475D-86D5-56AA6A2B019AQ47873103-C601A74B-859D-46A3-BEDF-A7329167609EQ50120034-6D6B6771-6E84-422C-89BD-FB20B2641129Q52668271-8D0B1D8B-4B44-4D99-A415-1DAE83ACB744Q55311740-FCB27F48-C01B-4010-8433-92049E2FB2EA
P2860
Omalizumab modulates bronchial reticular basement membrane thickness and eosinophil infiltration in severe persistent allergic asthma patients.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Omalizumab modulates bronchial ...... tent allergic asthma patients.
@ast
Omalizumab modulates bronchial ...... tent allergic asthma patients.
@en
Omalizumab modulates bronchial ...... tent allergic asthma patients.
@nl
type
label
Omalizumab modulates bronchial ...... tent allergic asthma patients.
@ast
Omalizumab modulates bronchial ...... tent allergic asthma patients.
@en
Omalizumab modulates bronchial ...... tent allergic asthma patients.
@nl
prefLabel
Omalizumab modulates bronchial ...... tent allergic asthma patients.
@ast
Omalizumab modulates bronchial ...... tent allergic asthma patients.
@en
Omalizumab modulates bronchial ...... tent allergic asthma patients.
@nl
P2093
P2860
P1476
Omalizumab modulates bronchial ...... stent allergic asthma patients
@en
P2093
A Chiappori
C Micheletto
L De Ferrari
R W Dal Negro
P2860
P304
P356
10.1177/039463201202500217
P577
2012-04-01T00:00:00Z